Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-3-22
pubmed:abstractText
To determine feasibility and efficacy of administering docetaxel and carboplatin chemotherapy followed by pelvic radiotherapy and then consolidation chemotherapy in patients with advanced or recurrent endometrial cancer.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1095-6859
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-7
pubmed:meshHeading
pubmed-meshheading:21239048-Adult, pubmed-meshheading:21239048-Aged, pubmed-meshheading:21239048-Aged, 80 and over, pubmed-meshheading:21239048-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21239048-Brachytherapy, pubmed-meshheading:21239048-Carboplatin, pubmed-meshheading:21239048-Carcinoma, Endometrioid, pubmed-meshheading:21239048-Combined Modality Therapy, pubmed-meshheading:21239048-Disease-Free Survival, pubmed-meshheading:21239048-Dose Fractionation, pubmed-meshheading:21239048-Endometrial Neoplasms, pubmed-meshheading:21239048-Female, pubmed-meshheading:21239048-Follow-Up Studies, pubmed-meshheading:21239048-Humans, pubmed-meshheading:21239048-Middle Aged, pubmed-meshheading:21239048-Neoplasm Recurrence, Local, pubmed-meshheading:21239048-Neoplasm Staging, pubmed-meshheading:21239048-Taxoids, pubmed-meshheading:21239048-Young Adult
pubmed:year
2011
pubmed:articleTitle
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.
pubmed:affiliation
Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA. gelle005@umn.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Research Support, N.I.H., Extramural